220 related articles for article (PubMed ID: 8937711)
1. 2-Amino-4-methylpyridine as a potent inhibitor of inducible NO synthase activity in vitro and in vivo.
Faraci WS; Nagel AA; Verdries KA; Vincent LA; Xu H; Nichols LE; Labasi JM; Salter ED; Pettipher ER
Br J Pharmacol; 1996 Nov; 119(6):1101-8. PubMed ID: 8937711
[TBL] [Abstract][Full Text] [Related]
2. Co-induction of nitric oxide synthase and cyclo-oxygenase: interactions between nitric oxide and prostanoids.
Swierkosz TA; Mitchell JA; Warner TD; Botting RM; Vane JR
Br J Pharmacol; 1995 Apr; 114(7):1335-42. PubMed ID: 7541688
[TBL] [Abstract][Full Text] [Related]
3. Glibenclamide-induced inhibition of the expression of inducible nitric oxide synthase in cultured macrophages and in the anaesthetized rat.
Wu CC; Thiemermann C; Vane JR
Br J Pharmacol; 1995 Mar; 114(6):1273-81. PubMed ID: 7542532
[TBL] [Abstract][Full Text] [Related]
4. Pharmacological characterization of guanidinoethyldisulphide (GED), a novel inhibitor of nitric oxide synthase with selectivity towards the inducible isoform.
Szabó C; Bryk R; Zingarelli B; Southan GJ; Gahman TC; Bhat V; Salzman AL; Wolff DJ
Br J Pharmacol; 1996 Aug; 118(7):1659-68. PubMed ID: 8842429
[TBL] [Abstract][Full Text] [Related]
5. The inhibitory effects of mercaptoalkylguanidines on cyclo-oxygenase activity.
Zingarelli B; Southan GJ; Gilad E; O'Connor M; Salzman AL; Szabó C
Br J Pharmacol; 1997 Feb; 120(3):357-66. PubMed ID: 9031736
[TBL] [Abstract][Full Text] [Related]
6. The inhibitory potency and selectivity of arginine substrate site nitric-oxide synthase inhibitors is solely determined by their affinity toward the different isoenzymes.
Boer R; Ulrich WR; Klein T; Mirau B; Haas S; Baur I
Mol Pharmacol; 2000 Nov; 58(5):1026-34. PubMed ID: 11040050
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of nitric oxide synthase by 1-(2-trifluoromethylphenyl) imidazole (TRIM) in vitro: antinociceptive and cardiovascular effects.
Handy RL; Harb HL; Wallace P; Gaffen Z; Whitehead KJ; Moore PK
Br J Pharmacol; 1996 Sep; 119(2):423-31. PubMed ID: 8886430
[TBL] [Abstract][Full Text] [Related]
8. The multiple organ dysfunction syndrome caused by endotoxin in the rat: attenuation of liver dysfunction by inhibitors of nitric oxide synthase.
Thiemermann C; Ruetten H; Wu CC; Vane JR
Br J Pharmacol; 1995 Dec; 116(7):2845-51. PubMed ID: 8680715
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of nitric oxide synthase aggravates cisplatin-induced nephrotoxicity: effect of 2-amino-4-methylpyridine.
Saad SY; Najjar TA; Daba MH; Al-Rikabi AC
Chemotherapy; 2002; 48(6):309-15. PubMed ID: 12673106
[TBL] [Abstract][Full Text] [Related]
10. Lipopolysaccharide-induced changes in plasma nitrite and nitrate concentrations in rats and mice: pharmacological evaluation of nitric oxide synthase inhibitors.
Tracey WR; Tse J; Carter G
J Pharmacol Exp Ther; 1995 Mar; 272(3):1011-5. PubMed ID: 7534350
[TBL] [Abstract][Full Text] [Related]
11. Regulation of prostaglandin production by nitric oxide; an in vivo analysis.
Salvemini D; Settle SL; Masferrer JL; Seibert K; Currie MG; Needleman P
Br J Pharmacol; 1995 Mar; 114(6):1171-8. PubMed ID: 7542531
[TBL] [Abstract][Full Text] [Related]
12. Modulation of IL-1-induced cartilage injury by NO synthase inhibitors: a comparative study with rat chondrocytes and cartilage entities.
Cipolletta C; Jouzeau JY; Gegout-Pottie P; Presle N; Bordji K; Netter P; Terlain B
Br J Pharmacol; 1998 Aug; 124(8):1719-27. PubMed ID: 9756389
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of constitutive nitric oxide synthase (NOS) by nitric oxide generated by inducible NOS after lipopolysaccharide administration provokes renal dysfunction in rats.
Schwartz D; Mendonca M; Schwartz I; Xia Y; Satriano J; Wilson CB; Blantz RC
J Clin Invest; 1997 Jul; 100(2):439-48. PubMed ID: 9218522
[TBL] [Abstract][Full Text] [Related]
14. Involvement of nitric oxide in the interferon-gamma-induced inhibition of growth hormone and prolactin secretion in anterior pituitary cell cultures.
Vankelecom H; Matthys P; Denef C
Mol Cell Endocrinol; 1997 May; 129(2):157-67. PubMed ID: 9202399
[TBL] [Abstract][Full Text] [Related]
15. Aminoguanidine attenuates the delayed circulatory failure and improves survival in rodent models of endotoxic shock.
Wu CC; Chen SJ; Szabó C; Thiemermann C; Vane JR
Br J Pharmacol; 1995 Apr; 114(8):1666-72. PubMed ID: 7541282
[TBL] [Abstract][Full Text] [Related]
16. L-N6-(1-iminoethyl)-lysine potently inhibits inducible nitric oxide synthase and is superior to NG-monomethyl-arginine in vitro and in vivo.
Stenger S; Thuring H; Rollinghoff M; Manning P; Bogdan C
Eur J Pharmacol; 1995 Dec; 294(2-3):703-12. PubMed ID: 8750736
[TBL] [Abstract][Full Text] [Related]
17. Attenuation of endotoxin-induced multiple organ dysfunction by 1-amino-2-hydroxy-guanidine, a potent inhibitor of inducible nitric oxide synthase.
Ruetten H; Southan GJ; Abate A; Thiemermann C
Br J Pharmacol; 1996 May; 118(2):261-70. PubMed ID: 8735625
[TBL] [Abstract][Full Text] [Related]
18. Time-dependent aggravation or attenuation of lipopolysaccharide-induced gastric injury by nitric oxide synthase inhibition.
Suliburk JW; Helmer KS; Kennison SD; Mercer DW; Robinson EK
J Surg Res; 2005 Dec; 129(2):265-71. PubMed ID: 16026802
[TBL] [Abstract][Full Text] [Related]
19. The inhibition by dantrolene of L-arginine transport and nitric oxide synthase in rat alveolar macrophages.
Chou TC; Li CY; Wu CC; Yen MH; Ding YA
Anesth Analg; 1998 May; 86(5):1065-9. PubMed ID: 9585299
[TBL] [Abstract][Full Text] [Related]
20. Spontaneous rearrangement of aminoalkylisothioureas into mercaptoalkylguanidines, a novel class of nitric oxide synthase inhibitors with selectivity towards the inducible isoform.
Southan GJ; Zingarelli B; O'Connor M; Salzman AL; Szabó C
Br J Pharmacol; 1996 Feb; 117(4):619-32. PubMed ID: 8646406
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
